Clinical Trial Update: Effect of Autologous Cord Blood Mononuclear Cells for Prevention of Bronchopulmonary Dysplasia or Death in Extremely Preterm Neonates [Phase 3]

View source ↗

Summary

Phase 3 trial investigating autologous cord blood mononuclear cells to prevent bronchopulmonary dysplasia or death in extremely preterm neonates.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• Autologous cord blood mononuclear cells

Snippet

Sponsor: Guangdong Women and Children Hospital | Conditions: BPD | Phase 3 | Status: UNKNOWN